Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic ...

Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...

JPMorgan Chase, Wells Fargo and BlackRock reported strong quarterly results to kick off earnings season, but concerns linger ...

Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 7. David ...

The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...

Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...

Former Pfizer CEO Ian Read and former CFO Frank D’Amelio announced their withdrawal from Starboard Value’s activist campaign ...

Starboard has amassed a stake worth about $1 billion, according to The Wall Street Journal, and is pressuring the firm to ...

As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard ...

Hedge fund Starboard Value's activist campaign targeting Pfizer (PFE) divides Wall Street, with analysts questioning the ...

Two former Pfizer executives published a statement saying they support the current company management as it gets pressured ...